NDC 14789-110
Levetiracetam in Sodium Chloride
Levetiracetam
Levetiracetam in Sodium Chloride is a Intravascular Injection in the Human Prescription Drug category. It is labeled and distributed by Nexus Pharmaceuticals Inc. The primary component is Levetiracetam.
| Product ID | 14789-110_084d3706-45cc-4913-a96e-74aeafaf059b |
| NDC | 14789-110 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Levetiracetam in Sodium Chloride |
| Generic Name | Levetiracetam |
| Dosage Form | Injection |
| Route of Administration | INTRAVASCULAR |
| Marketing Start Date | 2020-07-20 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA213532 |
| Labeler Name | Nexus Pharmaceuticals Inc |
| Substance Name | LEVETIRACETAM |
| Active Ingredient Strength | 5 mg/mL |
| Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |